CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease

Thomas Magg,Anna Shcherbina,Duran Arslan,Mukesh M Desai,Sarah Wall,Vanessa Mitsialis,Raffaele Conca,Ekrem Unal,Neslihan Karacabey,Anna Mukhina,Yulia Rodina,Prasad D Taur,David Illig,Benjamin Marquardt,Sebastian Hollizeck,Tim Jeske,Florian Gothe,Tilmann Schober,Meino Rohlfs,Sibylle Koletzko,Eberhard Lurz,Aleixo M Muise,Scott B Snapper,Fabian Hauck,Christoph Klein,Daniel Kotlarz

DOI: https://doi.org/10.1093/ibd/izz103

2019-10-18

Abstract:Background: Children with very early onset inflammatory bowel diseases (VEO-IBD) often have a refractory and severe disease course. A significant number of described VEO-IBD-causing monogenic disorders can be attributed to defects in immune-related genes. The diagnosis of the underlying primary immunodeficiency (PID) often has critical implications for the treatment of patients with IBD-like phenotypes. Methods: To identify the molecular etiology in 5 patients from 3 unrelated kindred with IBD-like symptoms, we conducted whole exome sequencing. Immune workup confirmed an underlying PID. Results: Whole exome sequencing revealed 3 novel CARMIL2 loss-of-function mutations in our patients. Immunophenotyping of peripheral blood mononuclear cells showed reduction of regulatory and effector memory T cells and impaired B cell class switching. The T cell proliferation and activation assays confirmed defective responses to CD28 costimulation, consistent with CARMIL2 deficiency. Conclusion: Our study highlights that human CARMIL2 deficiency can manifest with IBD-like symptoms. This example illustrates that early diagnosis of underlying PID is crucial for the treatment and prognosis of children with VEO-IBD.